Medpace Holdings, Inc.
NASDAQ:MEDP · NASDAQ Global Select
-$4.51 today
Vol 0.43M · Avg 0.36M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Stock Ticker Earnings Waterfall
NASDAQ:MEDP · Revenue to Net Income
Key Ratios
Analysis
$2.7B of revenue converted into $460.4M of net income for the selected period. Gross margin is 29.1% and net margin is 17.1%, showing how much revenue survives after costs and taxes. EPS is $15.92, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.5B +20.0% | $2.1B +11.8% | $1.9B +29.2% | $1.5B +27.8% | $1.1B | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $1.8B +21.8% | $1.5B +6.7% | $1.4B +32.5% | $1.0B +26.2% | $814.2M | $725.6M | $804.0M | $882.4M |
| Gross Profit | $760.6M +15.9% | $656.3M +25.1% | $524.5M +21.3% | $432.4M +31.8% | $328.2M | $8.9B | $7.6B | $6.2B |
| Gross Margin | 30.1% -1.1pp | 31.1% +3.3pp | 27.8% -1.8pp | 29.6% +0.9pp | 28.7% | 9.8% | 28.9% | 38.3% |
| Research & Development | $0 | $0 | $0 | $0 | $0 | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $197.6M +9.6% | $180.2M +11.7% | $161.4M +22.8% | $131.4M +21.2% | $108.4M | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $225.7M +7.8% | $209.4M +11.6% | $187.7M +22.1% | $153.7M +18.7% | $129.5M | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $28.1M -3.9% | $29.3M +11.1% | $26.3M +17.8% | $22.3M +5.8% | $21.1M | $374.2M | $1.2B | $631.8M |
| EBITDA | $570.5M +12.9% | $505.2M +39.4% | $362.5M +17.7% | $308.1M +38.1% | $223.1M | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | 22.5% -1.4pp | 24.0% +4.7pp | 19.2% -1.9pp | 21.1% +1.6pp | 19.5% | 5.6% | 46.3% | 42.0% |
| Operating Income | $534.9M +19.7% | $446.9M +32.7% | $336.8M +20.9% | $278.7M +40.3% | $198.6M | $12.3B | $14.0B | -$15.7B |
| Operating Margin | 21.1% -0.0pp | 21.2% +3.3pp | 17.9% -1.2pp | 19.1% +1.7pp | 17.4% | 16.6% | 24.1% | 22.0% |
| Interest Income | $0 -100.0% | $25.0M | $0 | $0 | $0 | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $0 | $0 -100.0% | $488.0K -83.2% | $2.9M +2666.7% | $105.0K | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | $7.4M -74.4% | $29.1M +2641.7% | -$1.1M -127.5% | $4.2M +28.6% | $3.2M | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | $542.4M +14.0% | $475.9M +41.8% | $335.7M +18.7% | $282.9M +40.1% | $201.9M | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | 21.4% -1.1pp | 22.6% +4.8pp | 17.8% -1.6pp | 19.4% +1.7pp | 17.7% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | $91.3M +27.6% | $71.5M +35.3% | $52.9M +41.0% | $37.5M +87.4% | $20.0M | $1.3B | -$1.6B | $745.2M |
| Net Income | $451.1M +11.6% | $404.4M +43.0% | $282.8M +15.3% | $245.4M +34.9% | $181.8M | $4.9B | $4.8B | $4.7B |
| Net Margin | 17.8% -1.3pp | 19.2% +4.2pp | 15.0% -1.8pp | 16.8% +0.9pp | 15.9% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | $16 +19.8% | $13 +42.0% | $9 +21.5% | $8 +49.6% | $5 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | $15 +21.0% | $13 +42.2% | $9 +22.0% | $7 +51.4% | $5 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $28.8M -6.8% | $31.0M +0.8% | $30.7M -5.1% | $32.4M -9.7% | $35.9M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $29.5M -7.8% | $32.0M +0.5% | $31.8M -5.4% | $33.7M -10.7% | $37.7M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Centene Corporation
NYSE:CNC
$29.94B
Illumina, Inc.
NASDAQ:ILMN
$24.07B
Waters Corporation
NYSE:WAT
$23.27B
West Pharmaceutical Services, Inc.
NYSE:WST
$22.86B
Quest Diagnostics Incorporated
NYSE:DGX
$21.89B
Hologic, Inc.
HOLX
$16.97B
Tenet Healthcare Corporation
NYSE:THC
$15.38B
Smith & Nephew plc
NYSE:SNN
$12.74B
ICON Public Limited Company
NASDAQ:ICLR
$10.97B
Tempus AI, Inc.
NASDAQ:TEM
$8.51B
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does MEDP generate?
Medpace Holdings, Inc. (MEDP) reported $2.53B of revenue in fiscal 2025.
Is MEDP profitable?
Medpace Holdings, Inc. (MEDP) reported $451.12M of net income, with a net margin of 17.8%.
Explore More
Continue the stock analysis
Jump to another research area for this company.